Genmab A (GMAB) Shares Outstanding: 2018-2020
- Genmab A's Shares Outstanding fell 21.89% to $114,830 in Q4 2020 from the same period last year, while for Dec 2020 it was $114,830, marking a year-over-year decrease of 21.89%. This contributed to the annual value of $114,830 for FY2020, which is 21.89% down from last year.
- Genmab A's Shares Outstanding amounted to $114,830 in Q4 2020, which was down 100.00% from $14.1 billion recorded in Q2 2020.
- Genmab A's 5-year Shares Outstanding high stood at $14.1 billion for Q2 2020, and its period low was $114,830 during Q4 2020.
- Its 3-year average for Shares Outstanding is $3.5 billion, with a median of $152,182 in 2018.
- Data for Genmab A's Shares Outstanding shows a maximum YoY dropped of 21.89% (in 2020) over the last 5 years.
- Quarterly analysis of 3 years shows Genmab A's Shares Outstanding stood at $157,354 in 2018, then decreased by 6.57% to $147,010 in 2019, then declined by 21.89% to $114,830 in 2020.
- Its Shares Outstanding stands at $114,830 for Q4 2020, versus $14.1 billion for Q2 2020 and $147,010 for Q4 2019.
